Practice innovation: Group health's initiative to avert opioid misuse and overdose among patients with chronic noncancer pain

Health Affairs

Volumn 30, Issue 8, 2011, Pages 1420-1424

  Trescott, Claire E ^a   Beck, Randi M ^b   Seelig, Michelle D ^b   Von Korff, Michael R ^a  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b Group Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; OPIATE; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ARTICLE; CHRONIC PAIN; DRUG EFFICACY; DRUG MISUSE; DRUG OVERDOSE; EDUCATION PROGRAM; ELECTRONIC MEDICAL RECORD; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH STATUS; HUMAN; MEDICAL INFORMATICS; PATIENT CARE PLANNING; PERSONAL EXPERIENCE; PRESCRIPTION; PRIMARY MEDICAL CARE; TREATMENT OUTCOME; HEALTH CARE DELIVERY; HEALTH SERVICES RESEARCH; INTOXICATION; NON PROFIT HOSPITAL; OPIATE ADDICTION; UNITED STATES;

ANALGESICS, OPIOID; CHRONIC PAIN; DELIVERY OF HEALTH CARE; DRUG PRESCRIPTIONS; HOSPITALS, VOLUNTARY; HUMANS; OPIOID-RELATED DISORDERS; ORGANIZATIONAL CASE STUDIES; OVERDOSE; WASHINGTON;

EID: 84855169025     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2011.0759     Document Type: Article

References (24)

1. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, et al. Trends in long-term opioid therapy for chronic noncancer pain. Pharmacoepidemiol Drug Saf. 2009;18(12):1166-75.
2. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain. 2004;109(3):514-9.
3. Braden JB, Fan MY, Edlund MJ, Martin BC, DeVries A, Sullivan MD. Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCare enrollees: results from the TROUP study. J Pain. 2008;9(11):1026-35.
4. Zerzan JT, Morden NE, Soumerai S, Ross-Degnan D, Roughhead E, Zhang F, et al. Trends and geographic variation of opiate medication use in state Medicaid fee-forservice programs, 1996 to 2002. Med Care. 2006;44(11):1005-10.
5. Meier B. Pain killer: a "wonder" drug's trail of addiction and death. Emmaus (PA): Rodale Press; 2003.
6. Von Korff M, Kolodny A, Deyo RA, Chou R. Long-term opioid therapy reconsidered. Ann Intern Med. Forthcoming.
7. Croft P, Blyth FM, van der Windt D. The global occurrence of chronic pain: an introduction. In: Croft P, Blyth F, van der Windt D, editors. Chronic pain epidemiology: from aetiology to public health. Oxford: Oxford University Press; 2010. p. 9-18.
8. Katz MH. Long-term opioid treatment of nonmalignant pain: a believer loses his faith. Arch Intern Med. 2010;170(16):1422-4.
9. White House Office of National Drug Control Policy. Epidemic: responding to America's prescription drug abuse crisis [Internet]. Washington (DC): The Office; 2011 [cited 2011 Jul 19]. http://www.whitehousedrugpolicy.gov/publications/pdf/rx_ abuse_plan.pdf.
10. Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. CPDD taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 2003;69(3):215-32.
11. Von Korff M, Deyo RA. Potent opioids for chronic musculoskeletal pain: flying blind? Pain. 2004; 109(3):207-9.
12. Franklin GM, Mai J, Wickizer T, Turner JA, Fluton-Kehoe D, Grant L. Opioid dosing trends and mortality in Washington State workers' compensation, 1996-2002. Am J Ind Med. 2005;48(2):91-9.
13. Agency Medical Directors' Group. Opioid dosing guideline for chronic non-cancer pain [Internet]. Olympia (WA): The Group; 2010 [cited 2011 Jul 28]. Available from: http:// www.agencymeddirectors.wa.gov/ opioiddosing.asp.
14. Larson EB, Greene S. Research networks: fulfilling the potential of the learning healthcare system through emerging research networks. In: Olsen L, McGinnis JM, editors. Redesigning the clinical effectiveness research paradigm: innovation and practice-based approaches. Washington (DC): National Academies Press; 2010. p. 307-22.
15. Von Korff M, Saunders K, Thomas Ray G, Boudreau D, Campbell C, Merrill J, et al. De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008;24(6):521-7.
16. Saunders KW, Dunn KM, Merrill JO, Sullivan M, Weisner C, Braden JB, et al. Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med. 2010;25(4):310-5.
17. Sullivan MD, Von Korff M, Banta-Green C, Merrill JO, Saunders K. Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain. 2010;149(2):345-53.
18. Von Korff M, Merrill JO, Rutter CM, Sullivan M, Campbell CI, Weisner C. Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain. 2011;152(6):1256-62.
19. Weisner CM, Campbell CI, Ray GT, Saunders K, Merrill JO, Banta-Green C, et al. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain. 2009;145(3): 287-93.
20. Dunn K, Saunders K, Rutter C, Banta-Green C, Merrill J, Sullivan M, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010; 152(2):85-92.
21. McLellan AT, Turner BJ. Chronic noncancer pain management and opioid overdose: time to change prescribing practices. Ann Intern Med. 2010;152(2):124.
22. Paulozzi LJ, Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and drug type. Pharmacoepidemio Drug Saf. 2008;17(1):997-1005.
23. Ballantyne JC. Pain medicine: repairing a fractured dream. Anesthesiology. 2011;114(2):243-6.
24. Womack JP, Jones DT. Lean consumption. Harv Bus Rev. 2005;83:58-68.